Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Familial Hypercholesterolaemia in the Era of Genetic Testing.

Current cardiology reports - 1 May 2016

Hughes D P, Viljoen A, Wierzbicki A S

Abstract excerpt

Familial hypercholesterolaemia (FH) is a relatively common autosomal dominant genetic condition leading to premature ischaemic vascular disease and mortality if left untreated. Currently, a universal consensus on the diagnostic criteria of FH does not exist but the diagnosis of FH largely relies on the evaluation of low density lipoprotein-cholesterol (LDL-C) levels, a careful documentation of family history, and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiovascular Diseases
Share to Cholesterol, LDL
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Testing

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Hyperlipoproteinemia Type II

Share to Mass Screening

Share to Receptors, LDL

Source

Identifiers

PMID: 27002618
DOI: 10.1007/s11886-016-0723-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Familial Hypercholesterolaemia in the Era of Genetic Testing.PMID 27002618Read ↗

Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes?Semantic proximity Read ↗

Genotype-guided diagnosis in familial hypercholesterolemia: population burden and cascade screening.Semantic proximity Read ↗

Beyond the Usual Suspects: Expanding on Mutations and Detection for Familial Hypercholesterolemia.Semantic proximity Read ↗

Genetic Testing and Risk Scores: Impact on Familial HypercholesterolemiaSemantic proximity Read ↗

Genetic testing for familial hypercholesterolemiaSemantic proximity Read ↗

New Approaches in Detection and Treatment of Familial Hypercholesterolemia.Semantic proximity Read ↗

Cardiovascular risk stratification in familial hypercholesterolaemia.Semantic proximity Read ↗

Familial hypercholesterolaemia: a pressing issue for European health care.Semantic proximity Read ↗

Familial Hypercholesterolemia: From Clinical Suspicion to Novel TreatmentsSemantic proximity Read ↗

[Familial hypercholesterolemia: epidemiology, genetics, diagnosis, and screening].Semantic proximity Read ↗

Are Genetic Tests for Atherosclerosis Ready for Routine Clinical Use?Semantic proximity Read ↗

Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.